Literature DB >> 14978142

Effects of sustained HIV-1 plasma viremia on HIV-1 Gag-specific CD4+ T cell maturation and function.

Brent E Palmer1, Eli Boritz, Cara C Wilson.   

Abstract

An in vitro proliferative defect has been observed in HIV-1-specific CD4(+) T cells from infected subjects with high-level plasma HIV-1 viremia. To determine the mechanism of this defect, HIV-1 Gag-specific CD4(+) T cells from treated and untreated HIV-1-infected subjects were analyzed for cytokine profile, proliferative capacity, and maturation state. Unexpectedly high frequencies of HIV-1-specific, IL-2-producing CD4(+) T cells were measured in subjects with low or undetectable plasma HIV-1 loads, regardless of treatment status, and IL-2 frequencies correlated inversely with viral loads. IL-2-producing CD4(+) T cells also primarily displayed a central memory (T(Cm); CCR7(+)CD45RA(-)) maturation phenotype, whereas IFN-gamma-producing cells were mostly effector memory (T(Em), CCR7(-)CD45RA(-)). Among Gag-specific, IFN-gamma-producing CD4(+) T cells, higher T(Em) frequencies and lower T(Cm) frequencies were observed in untreated, high viral load subjects than in subjects with low viral loads. The percentage of HIV-1 Gag-specific CD4(+) T(Cm) correlated inversely with HIV-1 viral load and directly with Gag-specific CD4(+) T cell proliferation, whereas the opposite relationships were observed for HIV-1-specific CD4(+) T(Em). These results suggest that HIV-1 viremia skews Gag-specific CD4(+) T cells away from an IL-2-producing T(Cm) phenotype and toward a poorly proliferating T(Em) phenotype, which may limit the effectiveness of the HIV-1-specific immune response.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14978142     DOI: 10.4049/jimmunol.172.5.3337

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  35 in total

1.  In vitro sensitization of T cells with DC-associated/delivered HIV constructs can induce a polyfunctional CTL response, memory T-cell response, and virus suppression.

Authors:  Swarali Kurle; Madhuri Thakar; Ashwini Shete; Ramesh Paranjape
Journal:  Viral Immunol       Date:  2012-01-10       Impact factor: 2.257

2.  Distinct kinetics of Gag-specific CD4+ and CD8+ T cell responses during acute HIV-1 infection.

Authors:  Catherine Riou; Vitaly V Ganusov; Suzanne Campion; Mandla Mlotshwa; Michael K P Liu; Victoria E Whale; Nilu Goonetilleke; Persephone Borrow; Guido Ferrari; Michael R Betts; Barton F Haynes; Andrew J McMichael; Clive M Gray
Journal:  J Immunol       Date:  2012-01-27       Impact factor: 5.422

3.  A phase IIa trial of the new tuberculosis vaccine, MVA85A, in HIV- and/or Mycobacterium tuberculosis-infected adults.

Authors:  Thomas J Scriba; Michele Tameris; Erica Smit; Linda van der Merwe; E Jane Hughes; Blessing Kadira; Katya Mauff; Sizulu Moyo; Nathaniel Brittain; Alison Lawrie; Humphrey Mulenga; Marwou de Kock; Lebohang Makhethe; Esme Janse van Rensburg; Sebastian Gelderbloem; Ashley Veldsman; Mark Hatherill; Hendrik Geldenhuys; Adrian V S Hill; Anthony Hawkridge; Gregory D Hussey; Willem A Hanekom; Helen McShane; Hassan Mahomed
Journal:  Am J Respir Crit Care Med       Date:  2012-01-26       Impact factor: 21.405

4.  Frequency of beryllium-specific, central memory CD4+ T cells in blood determines proliferative response.

Authors:  Andrew P Fontenot; Brent E Palmer; Andrew K Sullivan; Fenneke G Joslin; Cara C Wilson; Lisa A Maier; Lee S Newman; Brian L Kotzin
Journal:  J Clin Invest       Date:  2005-09-08       Impact factor: 14.808

5.  Impact of immune plasticity on development of cellular memory responses to human immunodeficiency virus type 1.

Authors:  Michael A Kolber
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

6.  Expansion and contraction of HIV-specific CD4 T cells with short bursts of viremia, but physical loss of the majority of these cells with sustained viral replication.

Authors:  Nilufer Seth; Daniel Kaufmann; Timothy Lahey; Eric S Rosenberg; Kai W Wucherpfennig
Journal:  J Immunol       Date:  2005-11-15       Impact factor: 5.422

7.  Up-regulation of programmed death-1 expression on beryllium-specific CD4+ T cells in chronic beryllium disease.

Authors:  Brent E Palmer; Douglas G Mack; Allison K Martin; May Gillespie; Margaret M Mroz; Lisa A Maier; Andrew P Fontenot
Journal:  J Immunol       Date:  2008-02-15       Impact factor: 5.422

8.  Effective B cell activation in vitro during viremic HIV-1 infection with surrogate T cell stimulation.

Authors:  Lindsay K Nicholson; Harsh Pratap; Elisabeth Bowers; Elise Gunzburger; Srinivasa R Bandi; Edward M Gardner; Brent E Palmer; Timothy Wright; John Kittelson; Edward N Janoff
Journal:  Immunobiology       Date:  2018-09-07       Impact factor: 3.144

Review 9.  Distinctive features of CD4+ T cell dysfunction in chronic viral infections.

Authors:  Antigoni Morou; Brent E Palmer; Daniel E Kaufmann
Journal:  Curr Opin HIV AIDS       Date:  2014-09       Impact factor: 4.283

10.  IL-7 receptor heterogeneity as a mechanism for repertoire change during postdepletional homeostatic proliferation and its relation to costimulation blockade-resistant rejection.

Authors:  He Xu; Victoria A Bendersky; Todd V Brennan; Jaclyn R Espinosa; Allan D Kirk
Journal:  Am J Transplant       Date:  2017-12-12       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.